JP2019523282A5 - - Google Patents

Download PDF

Info

Publication number
JP2019523282A5
JP2019523282A5 JP2019505170A JP2019505170A JP2019523282A5 JP 2019523282 A5 JP2019523282 A5 JP 2019523282A5 JP 2019505170 A JP2019505170 A JP 2019505170A JP 2019505170 A JP2019505170 A JP 2019505170A JP 2019523282 A5 JP2019523282 A5 JP 2019523282A5
Authority
JP
Japan
Prior art keywords
essential oil
pharmaceutical composition
oil
composition according
cannabis extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019505170A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019523282A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2017/050815 external-priority patent/WO2018023164A1/en
Publication of JP2019523282A publication Critical patent/JP2019523282A/ja
Publication of JP2019523282A5 publication Critical patent/JP2019523282A5/ja
Pending legal-status Critical Current

Links

JP2019505170A 2016-08-03 2017-08-03 大麻組成物 Pending JP2019523282A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662370303P 2016-08-03 2016-08-03
US62/370,303 2016-08-03
PCT/AU2017/050815 WO2018023164A1 (en) 2016-08-03 2017-08-03 Cannabis composition

Publications (2)

Publication Number Publication Date
JP2019523282A JP2019523282A (ja) 2019-08-22
JP2019523282A5 true JP2019523282A5 (https=) 2020-01-23

Family

ID=61072439

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019505170A Pending JP2019523282A (ja) 2016-08-03 2017-08-03 大麻組成物

Country Status (11)

Country Link
US (2) US20190307719A1 (https=)
EP (1) EP3493799A4 (https=)
JP (1) JP2019523282A (https=)
KR (1) KR20190033590A (https=)
CN (1) CN109789124A (https=)
AU (5) AU2017307644B2 (https=)
CA (1) CA3031811A1 (https=)
CL (1) CL2019000268A1 (https=)
PE (1) PE20200676A1 (https=)
SG (1) SG11201900596XA (https=)
WO (1) WO2018023164A1 (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018023166A1 (en) 2016-08-03 2018-02-08 Zelda Therapeutics Operations Pty Ltd Cannabis composition
SG11201900665VA (en) 2016-08-03 2019-02-27 Zelda Therapeutics Operations Pty Ltd Cannabis composition
JP2019523282A (ja) 2016-08-03 2019-08-22 ゼルダ セラピューティクス オペレーションズ ピーティーワイ リミテッド 大麻組成物
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US11484510B2 (en) * 2017-08-28 2022-11-01 Apirx Pharmaceutical Usa, Llc Method to treat vitiligo
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
WO2019220324A2 (en) * 2018-05-14 2019-11-21 Buzzelet Development And Technologies Ltd Terpene-enriched cannabinoid compositions and uses thereof in the treatment of infectious conditions
US10736869B2 (en) * 2018-07-16 2020-08-11 ECS Health Sciences, Inc. Compositions and methods related to cannabinoids, terpenoids and essential oils
US11013715B2 (en) * 2018-07-19 2021-05-25 Vertosa, Inc. Nanoemulsion hydrophobic substances
IL261774B (en) * 2018-09-13 2020-04-30 Unv Medicine Ltd Preparations for the treatment of skin problems
WO2020077153A1 (en) 2018-10-10 2020-04-16 Canopy Holdings, LLC Synthesis of cannabigerol
WO2020086291A1 (en) 2018-10-22 2020-04-30 Jones Lisa Marie Topical compositions incorporating cannabis
WO2020123383A1 (en) * 2018-12-10 2020-06-18 Natural Extraction Systems, LLC Compositions with novel cannabinoid and terpene profiles
WO2020129045A1 (en) * 2018-12-19 2020-06-25 Pathway RX Inc. Novel cannabis lines and extracts for treating skin disorders
WO2020129044A1 (en) * 2018-12-19 2020-06-25 Pathway RX Inc. Novel cannabis lines and extracts for skin rejuvenation and skin protection
WO2020129043A1 (en) * 2018-12-19 2020-06-25 Pathway RX Inc. Novel cannabis sativa lines and extracts with anti-cancer properties
WO2020136648A1 (en) * 2018-12-25 2020-07-02 Epm Group Inc. Cannabidiolic acid esters for cosmetic or edible compositions
EP3906025A4 (en) * 2019-01-04 2022-09-21 Columbia Care LLC CANNABINOID TOPICAL FORMULATIONS
US11246310B2 (en) * 2019-02-08 2022-02-15 Global Biolife Inc. Insect repelling composition
US20200345686A1 (en) * 2019-04-30 2020-11-05 Vcp Ip Holdings, Llc, Limited Liability Company Delaware Compositions and methods for treating skin and neuropathic conditions and disorders
US10717056B1 (en) 2019-09-09 2020-07-21 Michael Cem Gokay Method and apparatus for purification of cannabinoid extracts
US20210093539A1 (en) * 2019-09-30 2021-04-01 Concept Matrix Solutions Topical cosmetic
US12343315B2 (en) * 2019-10-21 2025-07-01 Avicanna Inc. Topical cannabinoid compositions for clear skin
US10941131B1 (en) * 2019-10-28 2021-03-09 Pure Tonic Concentrates, LLC Conversion of cannabidiol or delta-9 tetrahydrocannabinolic acid to delta-9 tetrahydrocannabinol and delta-8 tetrahydrocannabinol in nontoxic heterogeneous mixtures
CN118161552A (zh) * 2019-12-19 2024-06-11 史蒂文·罗斯斯坦 富含多酚化合物的提取物以及相关方法
WO2021127559A1 (en) * 2019-12-19 2021-06-24 Natural Extraction Systems, LLC Compositions comprising cannabinoid anions and anti-nucleating agents
US11590187B2 (en) * 2020-01-14 2023-02-28 Shaman Naturals, Llc Antimicrobial compositions
US20210346276A1 (en) * 2020-05-05 2021-11-11 Gm Pharmaceuticals, Inc. Skincare compositions containing cannabidiol
US20210369802A1 (en) * 2020-06-01 2021-12-02 James Chuang Cannabis plant formulations and methods of delivery
US20220054446A1 (en) * 2020-08-18 2022-02-24 Yvette Rose Webb Targeted treatment with a topical cream of cannabinoids, terpenes, and essential oils
DK181329B1 (en) * 2021-05-04 2023-08-16 Cs Medica As Nasal sleep spray composition, method for its provision, and receptacle and kit comprising said composition
WO2023152748A1 (en) * 2022-02-13 2023-08-17 Reagenics Research Ltd. Plant-based skin preparations and use thereof
WO2025231524A1 (en) * 2024-05-08 2025-11-13 Heyday RX Pty Ltd Cannabinoid compositions

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949582B1 (en) * 1999-05-27 2005-09-27 Wallace Walter H Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
DE10051427C1 (de) * 2000-10-17 2002-06-13 Adam Mueller Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte
JP2004002237A (ja) * 2002-05-31 2004-01-08 Noriko Yagi 老化防止ハーブ
EP1559423A1 (en) * 2004-02-02 2005-08-03 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Medicinal acidic cannabinoids
US9035130B2 (en) * 2007-05-31 2015-05-19 Gw Pharma Limited Reference plant, a method for its production, extracts obtained therefrom and their use
GB2478595B (en) * 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
ES2541485T3 (es) * 2010-10-19 2015-07-21 Parenteral, A.S. Composición para el tratamiento de enfermedades inflamatorias, la cual comprende ácidos boswéllicos y cannabidiol
US20120264818A1 (en) * 2011-04-15 2012-10-18 Jon Newland Topical Compositions with Cannabis Extracts
US20130184354A1 (en) * 2012-01-13 2013-07-18 Donna K. Jackson Silicone and Hylauronic Acid (HLA) Delivery Systems for Products by Sustainable Processes for Medical Uses Including Wound Management
US20130274321A1 (en) * 2012-03-30 2013-10-17 Jon Newland Topical Compositions with Cannabis Extracts
WO2013165251A1 (en) * 2012-05-03 2013-11-07 Echo Pharmaceuticals B.V. Cannabis plant isolate comprising /\9-tetrahydrocannabinol and a method for preparing such an isolate
CA2895805A1 (en) * 2012-12-18 2014-06-26 Kotzker Consulting Llc Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
EP2968259B1 (en) * 2013-03-14 2022-09-14 SC Laboratories Inc. Bioactive concentrates and uses thereof
WO2014145490A2 (en) * 2013-03-15 2014-09-18 Biotech Institute, Llc Breeding, production, processing and use of specialty cannabis
US9095563B2 (en) * 2013-09-26 2015-08-04 Ronald D. Sekura Topical treatments incorporating Cannabis sp. derived botanical drug product
HRP20221172T1 (hr) * 2013-10-29 2023-02-03 Biotech Institute, Llc Uzgoj, proizvodnja, prerada i uporaba specijalnog sinsemilla kanabisa
JP6377423B2 (ja) * 2014-06-17 2018-08-22 ロート製薬株式会社 外用組成物
EP3160445B1 (en) * 2014-06-26 2021-10-20 Island Breeze Systems Ca, LLC Mdi related products and methods of use
AU2015308546A1 (en) * 2014-08-25 2017-04-13 Clk Consult V/ Carsten Leonhard Knudsen Device with compositions for delivery to the lungs, the oral mucosa and the brain
CA2859930A1 (en) * 2014-09-22 2016-03-22 Antony Paul Hornby A cannabis topical from heat treated cocount oil
BR122021018502B1 (pt) * 2014-10-21 2022-05-03 United Cannabis Corp Formulação de canabinoide líquida
US20160309774A1 (en) * 2015-04-27 2016-10-27 Michael D. Wand Terpene carrier
EP3380096A4 (en) * 2015-11-24 2019-10-23 Constance Therapeutics, Inc. CANNABIS OIL COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
EP3283065A4 (en) * 2015-12-09 2018-12-26 Poviva Tea, LLC Methods for formulating orally ingestible compositions comprising lipophilic active agents
AU2017210319A1 (en) * 2016-01-20 2018-08-23 Flurry Powders, Llc Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
PT3429580T (pt) * 2016-03-16 2025-08-12 Buzzelet Development And Technologies Ltd Composição de canabinoides enriquecida em terpenos
IL246790A0 (en) * 2016-07-14 2016-09-29 Friedman Doron Self-dissolving compounds of cannabinoids
JP2019523282A (ja) 2016-08-03 2019-08-22 ゼルダ セラピューティクス オペレーションズ ピーティーワイ リミテッド 大麻組成物

Similar Documents

Publication Publication Date Title
JP2019523282A5 (https=)
AU2021240296B2 (en) Cannabis Composition
JP7139559B2 (ja) 大麻組成物
JP2020524151A5 (https=)
JP2019523283A5 (https=)
US11020357B2 (en) Compound for use in relief of pain and method to produce thereof
JP2019530751A5 (https=)
JP2019523283A (ja) 大麻組成物
Wang et al. The genus Schefflera: A review of traditional uses, phytochemistry and pharmacology
KR20210071941A (ko) 오피오이드 절약을 위한 조성물 및 방법
BR112021021029A2 (pt) Preparação de canabidiol, e, método para tratar um paciente que sofre de crises associadas ao complexo de esclerose tuberosa
Wang et al. Toona sinensis fruit polyphenols alleviate cerebral ischemia-reperfusion injury in rats by inhibiting MAPK signaling pathways and NLRP3 inflammasome/pyroptosis
Aswar et al. Estrogenic activity of friedelin rich fraction (IND-HE) separated from Cissus quadrangularis and its effect on female sexual function
RU2015137043A (ru) Жидкие ментол-содержащие композиции
EP3817735A1 (en) Cannabinoid composition and method for treating ptsd and/or anxiety
Azhari et al. The use of essential oils in atopic dermatitis: a review
Ahn et al. Anti-inflammatory effects of natural volatile organic compounds from Pinus koraiensis and Larix kaempferi in mouse model
Babbar et al. Unveiling the phyto-restorative potential of ethereal distillates for atopic dermatitis: an advanced therapeutic approach
US20230338397A1 (en) Composition comprising cannabinoids, and/or terpens, and methods of using same
US20240350570A1 (en) Topical skin care preparation comprising ephedra viridis
Prokai-Tatrai et al. Non-feminizing estrogens do not exhibit antidepressant-like activity
Alijanpour et al. Hawthorn berries ethanolic extract lowered polycystic ovarian syndrome-elevated testosterone level and improved the altered ovaries structure
US20190183956A1 (en) Use of a clove oil fraction
Krassnig et al. Herbal treatment options for post-viral symptoms and long COVID
Adams Plant Medicines for Clinical Trial